The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global PRRS Vaccines Market Research Report 2025
Synopsis
There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.
The global PRRS Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for PRRS Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PRRS Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of PRRS Vaccines include CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva, ChengDu Tecbond, Veterinary, Ringpu Biology and Qilu Animal, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PRRS Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PRRS Vaccines.
Report Scope
The PRRS Vaccines market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PRRS Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PRRS Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Zoetis
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Government Tender
Market Sales
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PRRS Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of PRRS Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of PRRS Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.
The global PRRS Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for PRRS Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PRRS Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of PRRS Vaccines include CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva, ChengDu Tecbond, Veterinary, Ringpu Biology and Qilu Animal, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PRRS Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PRRS Vaccines.
Report Scope
The PRRS Vaccines market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PRRS Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PRRS Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Zoetis
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Government Tender
Market Sales
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PRRS Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of PRRS Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of PRRS Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 PRRS Vaccines Market Overview
1.1 Product Definition
1.2 PRRS Vaccines Segment by Type
1.2.1 Global PRRS Vaccines Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 PRRS Vaccines Segment by Application
1.3.1 Global PRRS Vaccines Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Market Growth Prospects
1.4.1 Global PRRS Vaccines Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global PRRS Vaccines Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global PRRS Vaccines Production Estimates and Forecasts (2019-2030)
1.4.4 Global PRRS Vaccines Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global PRRS Vaccines Production Market Share by Manufacturers (2019-2024)
2.2 Global PRRS Vaccines Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of PRRS Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global PRRS Vaccines Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of PRRS Vaccines, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of PRRS Vaccines, Product Offered and Application
2.8 Global Key Manufacturers of PRRS Vaccines, Date of Enter into This Industry
2.9 PRRS Vaccines Market Competitive Situation and Trends
2.9.1 PRRS Vaccines Market Concentration Rate
2.9.2 Global 5 and 10 Largest PRRS Vaccines Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 PRRS Vaccines Production by Region
3.1 Global PRRS Vaccines Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global PRRS Vaccines Production Value by Region (2019-2030)
3.2.1 Global PRRS Vaccines Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of PRRS Vaccines by Region (2025-2030)
3.3 Global PRRS Vaccines Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global PRRS Vaccines Production by Region (2019-2030)
3.4.1 Global PRRS Vaccines Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of PRRS Vaccines by Region (2025-2030)
3.5 Global PRRS Vaccines Market Price Analysis by Region (2019-2024)
3.6 Global PRRS Vaccines Production and Value, Year-over-Year Growth
3.6.1 North America PRRS Vaccines Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe PRRS Vaccines Production Value Estimates and Forecasts (2019-2030)
3.6.3 China PRRS Vaccines Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan PRRS Vaccines Production Value Estimates and Forecasts (2019-2030)
4 PRRS Vaccines Consumption by Region
4.1 Global PRRS Vaccines Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global PRRS Vaccines Consumption by Region (2019-2030)
4.2.1 Global PRRS Vaccines Consumption by Region (2019-2024)
4.2.2 Global PRRS Vaccines Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America PRRS Vaccines Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America PRRS Vaccines Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe PRRS Vaccines Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe PRRS Vaccines Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific PRRS Vaccines Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific PRRS Vaccines Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa PRRS Vaccines Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa PRRS Vaccines Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global PRRS Vaccines Production by Type (2019-2030)
5.1.1 Global PRRS Vaccines Production by Type (2019-2024)
5.1.2 Global PRRS Vaccines Production by Type (2025-2030)
5.1.3 Global PRRS Vaccines Production Market Share by Type (2019-2030)
5.2 Global PRRS Vaccines Production Value by Type (2019-2030)
5.2.1 Global PRRS Vaccines Production Value by Type (2019-2024)
5.2.2 Global PRRS Vaccines Production Value by Type (2025-2030)
5.2.3 Global PRRS Vaccines Production Value Market Share by Type (2019-2030)
5.3 Global PRRS Vaccines Price by Type (2019-2030)
6 Segment by Application
6.1 Global PRRS Vaccines Production by Application (2019-2030)
6.1.1 Global PRRS Vaccines Production by Application (2019-2024)
6.1.2 Global PRRS Vaccines Production by Application (2025-2030)
6.1.3 Global PRRS Vaccines Production Market Share by Application (2019-2030)
6.2 Global PRRS Vaccines Production Value by Application (2019-2030)
6.2.1 Global PRRS Vaccines Production Value by Application (2019-2024)
6.2.2 Global PRRS Vaccines Production Value by Application (2025-2030)
6.2.3 Global PRRS Vaccines Production Value Market Share by Application (2019-2030)
6.3 Global PRRS Vaccines Price by Application (2019-2030)
7 Key Companies Profiled
7.1 CAHIC
7.1.1 CAHIC PRRS Vaccines Corporation Information
7.1.2 CAHIC PRRS Vaccines Product Portfolio
7.1.3 CAHIC PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.1.4 CAHIC Main Business and Markets Served
7.1.5 CAHIC Recent Developments/Updates
7.2 Merial
7.2.1 Merial PRRS Vaccines Corporation Information
7.2.2 Merial PRRS Vaccines Product Portfolio
7.2.3 Merial PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Merial Main Business and Markets Served
7.2.5 Merial Recent Developments/Updates
7.3 MSD Animal Health
7.3.1 MSD Animal Health PRRS Vaccines Corporation Information
7.3.2 MSD Animal Health PRRS Vaccines Product Portfolio
7.3.3 MSD Animal Health PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.3.4 MSD Animal Health Main Business and Markets Served
7.3.5 MSD Animal Health Recent Developments/Updates
7.4 Chopper Biology
7.4.1 Chopper Biology PRRS Vaccines Corporation Information
7.4.2 Chopper Biology PRRS Vaccines Product Portfolio
7.4.3 Chopper Biology PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Chopper Biology Main Business and Markets Served
7.4.5 Chopper Biology Recent Developments/Updates
7.5 Ceva
7.5.1 Ceva PRRS Vaccines Corporation Information
7.5.2 Ceva PRRS Vaccines Product Portfolio
7.5.3 Ceva PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Ceva Main Business and Markets Served
7.5.5 Ceva Recent Developments/Updates
7.6 ChengDu Tecbond
7.6.1 ChengDu Tecbond PRRS Vaccines Corporation Information
7.6.2 ChengDu Tecbond PRRS Vaccines Product Portfolio
7.6.3 ChengDu Tecbond PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.6.4 ChengDu Tecbond Main Business and Markets Served
7.6.5 ChengDu Tecbond Recent Developments/Updates
7.7 Veterinary
7.7.1 Veterinary PRRS Vaccines Corporation Information
7.7.2 Veterinary PRRS Vaccines Product Portfolio
7.7.3 Veterinary PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Veterinary Main Business and Markets Served
7.7.5 Veterinary Recent Developments/Updates
7.8 Ringpu Biology
7.8.1 Ringpu Biology PRRS Vaccines Corporation Information
7.8.2 Ringpu Biology PRRS Vaccines Product Portfolio
7.8.3 Ringpu Biology PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Ringpu Biology Main Business and Markets Served
7.7.5 Ringpu Biology Recent Developments/Updates
7.9 Qilu Animal
7.9.1 Qilu Animal PRRS Vaccines Corporation Information
7.9.2 Qilu Animal PRRS Vaccines Product Portfolio
7.9.3 Qilu Animal PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Qilu Animal Main Business and Markets Served
7.9.5 Qilu Animal Recent Developments/Updates
7.10 DHN
7.10.1 DHN PRRS Vaccines Corporation Information
7.10.2 DHN PRRS Vaccines Product Portfolio
7.10.3 DHN PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.10.4 DHN Main Business and Markets Served
7.10.5 DHN Recent Developments/Updates
7.11 CAVAC
7.11.1 CAVAC PRRS Vaccines Corporation Information
7.11.2 CAVAC PRRS Vaccines Product Portfolio
7.11.3 CAVAC PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.11.4 CAVAC Main Business and Markets Served
7.11.5 CAVAC Recent Developments/Updates
7.12 Komipharm
7.12.1 Komipharm PRRS Vaccines Corporation Information
7.12.2 Komipharm PRRS Vaccines Product Portfolio
7.12.3 Komipharm PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Komipharm Main Business and Markets Served
7.12.5 Komipharm Recent Developments/Updates
7.13 Agrovet
7.13.1 Agrovet PRRS Vaccines Corporation Information
7.13.2 Agrovet PRRS Vaccines Product Portfolio
7.13.3 Agrovet PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Agrovet Main Business and Markets Served
7.13.5 Agrovet Recent Developments/Updates
7.14 Bioveta
7.14.1 Bioveta PRRS Vaccines Corporation Information
7.14.2 Bioveta PRRS Vaccines Product Portfolio
7.14.3 Bioveta PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Bioveta Main Business and Markets Served
7.14.5 Bioveta Recent Developments/Updates
7.15 Jinyu Bio-Technology
7.15.1 Jinyu Bio-Technology PRRS Vaccines Corporation Information
7.15.2 Jinyu Bio-Technology PRRS Vaccines Product Portfolio
7.15.3 Jinyu Bio-Technology PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Jinyu Bio-Technology Main Business and Markets Served
7.15.5 Jinyu Bio-Technology Recent Developments/Updates
7.16 Institutul Pasteur
7.16.1 Institutul Pasteur PRRS Vaccines Corporation Information
7.16.2 Institutul Pasteur PRRS Vaccines Product Portfolio
7.16.3 Institutul Pasteur PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Institutul Pasteur Main Business and Markets Served
7.16.5 Institutul Pasteur Recent Developments/Updates
7.17 MVP
7.17.1 MVP PRRS Vaccines Corporation Information
7.17.2 MVP PRRS Vaccines Product Portfolio
7.17.3 MVP PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.17.4 MVP Main Business and Markets Served
7.17.5 MVP Recent Developments/Updates
7.18 Tecon
7.18.1 Tecon PRRS Vaccines Corporation Information
7.18.2 Tecon PRRS Vaccines Product Portfolio
7.18.3 Tecon PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.18.4 Tecon Main Business and Markets Served
7.18.5 Tecon Recent Developments/Updates
7.19 Zoetis
7.19.1 Zoetis PRRS Vaccines Corporation Information
7.19.2 Zoetis PRRS Vaccines Product Portfolio
7.19.3 Zoetis PRRS Vaccines Production, Value, Price and Gross Margin (2019-2024)
7.19.4 Zoetis Main Business and Markets Served
7.19.5 Zoetis Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 PRRS Vaccines Industry Chain Analysis
8.2 PRRS Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 PRRS Vaccines Production Mode & Process
8.4 PRRS Vaccines Sales and Marketing
8.4.1 PRRS Vaccines Sales Channels
8.4.2 PRRS Vaccines Distributors
8.5 PRRS Vaccines Customers
9 PRRS Vaccines Market Dynamics
9.1 PRRS Vaccines Industry Trends
9.2 PRRS Vaccines Market Drivers
9.3 PRRS Vaccines Market Challenges
9.4 PRRS Vaccines Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global PRRS Vaccines Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global PRRS Vaccines Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global PRRS Vaccines Production Capacity (K Units) by Manufacturers in 2023
Table 4. Global PRRS Vaccines Production by Manufacturers (2019-2024) & (K Units)
Table 5. Global PRRS Vaccines Production Market Share by Manufacturers (2019-2024)
Table 6. Global PRRS Vaccines Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global PRRS Vaccines Production Value Share by Manufacturers (2019-2024)
Table 8. Global PRRS Vaccines Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PRRS Vaccines as of 2023)
Table 10. Global Market PRRS Vaccines Average Price by Manufacturers (USD/Unit) & (2019-2024)
Table 11. Manufacturers PRRS Vaccines Production Sites and Area Served
Table 12. Manufacturers PRRS Vaccines Product Types
Table 13. Global PRRS Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global PRRS Vaccines Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global PRRS Vaccines Production Value (US$ Million) by Region (2019-2024)
Table 17. Global PRRS Vaccines Production Value Market Share by Region (2019-2024)
Table 18. Global PRRS Vaccines Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global PRRS Vaccines Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global PRRS Vaccines Production Comparison by Region: 2019 VS 2023 VS 2030 (K Units)
Table 21. Global PRRS Vaccines Production (K Units) by Region (2019-2024)
Table 22. Global PRRS Vaccines Production Market Share by Region (2019-2024)
Table 23. Global PRRS Vaccines Production (K Units) Forecast by Region (2025-2030)
Table 24. Global PRRS Vaccines Production Market Share Forecast by Region (2025-2030)
Table 25. Global PRRS Vaccines Market Average Price (USD/Unit) by Region (2019-2024)
Table 26. Global PRRS Vaccines Market Average Price (USD/Unit) by Region (2025-2030)
Table 27. Global PRRS Vaccines Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (K Units)
Table 28. Global PRRS Vaccines Consumption by Region (2019-2024) & (K Units)
Table 29. Global PRRS Vaccines Consumption Market Share by Region (2019-2024)
Table 30. Global PRRS Vaccines Forecasted Consumption by Region (2025-2030) & (K Units)
Table 31. Global PRRS Vaccines Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America PRRS Vaccines Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 33. North America PRRS Vaccines Consumption by Country (2019-2024) & (K Units)
Table 34. North America PRRS Vaccines Consumption by Country (2025-2030) & (K Units)
Table 35. Europe PRRS Vaccines Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 36. Europe PRRS Vaccines Consumption by Country (2019-2024) & (K Units)
Table 37. Europe PRRS Vaccines Consumption by Country (2025-2030) & (K Units)
Table 38. Asia Pacific PRRS Vaccines Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (K Units)
Table 39. Asia Pacific PRRS Vaccines Consumption by Region (2019-2024) & (K Units)
Table 40. Asia Pacific PRRS Vaccines Consumption by Region (2025-2030) & (K Units)
Table 41. Latin America, Middle East & Africa PRRS Vaccines Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 42. Latin America, Middle East & Africa PRRS Vaccines Consumption by Country (2019-2024) & (K Units)
Table 43. Latin America, Middle East & Africa PRRS Vaccines Consumption by Country (2025-2030) & (K Units)
Table 44. Global PRRS Vaccines Production (K Units) by Type (2019-2024)
Table 45. Global PRRS Vaccines Production (K Units) by Type (2025-2030)
Table 46. Global PRRS Vaccines Production Market Share by Type (2019-2024)
Table 47. Global PRRS Vaccines Production Market Share by Type (2025-2030)
Table 48. Global PRRS Vaccines Production Value (US$ Million) by Type (2019-2024)
Table 49. Global PRRS Vaccines Production Value (US$ Million) by Type (2025-2030)
Table 50. Global PRRS Vaccines Production Value Share by Type (2019-2024)
Table 51. Global PRRS Vaccines Production Value Share by Type (2025-2030)
Table 52. Global PRRS Vaccines Price (USD/Unit) by Type (2019-2024)
Table 53. Global PRRS Vaccines Price (USD/Unit) by Type (2025-2030)
Table 54. Global PRRS Vaccines Production (K Units) by Application (2019-2024)
Table 55. Global PRRS Vaccines Production (K Units) by Application (2025-2030)
Table 56. Global PRRS Vaccines Production Market Share by Application (2019-2024)
Table 57. Global PRRS Vaccines Production Market Share by Application (2025-2030)
Table 58. Global PRRS Vaccines Production Value (US$ Million) by Application (2019-2024)
Table 59. Global PRRS Vaccines Production Value (US$ Million) by Application (2025-2030)
Table 60. Global PRRS Vaccines Production Value Share by Application (2019-2024)
Table 61. Global PRRS Vaccines Production Value Share by Application (2025-2030)
Table 62. Global PRRS Vaccines Price (USD/Unit) by Application (2019-2024)
Table 63. Global PRRS Vaccines Price (USD/Unit) by Application (2025-2030)
Table 64. CAHIC PRRS Vaccines Corporation Information
Table 65. CAHIC Specification and Application
Table 66. CAHIC PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 67. CAHIC Main Business and Markets Served
Table 68. CAHIC Recent Developments/Updates
Table 69. Merial PRRS Vaccines Corporation Information
Table 70. Merial Specification and Application
Table 71. Merial PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Merial Main Business and Markets Served
Table 73. Merial Recent Developments/Updates
Table 74. MSD Animal Health PRRS Vaccines Corporation Information
Table 75. MSD Animal Health Specification and Application
Table 76. MSD Animal Health PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. MSD Animal Health Main Business and Markets Served
Table 78. MSD Animal Health Recent Developments/Updates
Table 79. Chopper Biology PRRS Vaccines Corporation Information
Table 80. Chopper Biology Specification and Application
Table 81. Chopper Biology PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Chopper Biology Main Business and Markets Served
Table 83. Chopper Biology Recent Developments/Updates
Table 84. Ceva PRRS Vaccines Corporation Information
Table 85. Ceva Specification and Application
Table 86. Ceva PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Ceva Main Business and Markets Served
Table 88. Ceva Recent Developments/Updates
Table 89. ChengDu Tecbond PRRS Vaccines Corporation Information
Table 90. ChengDu Tecbond Specification and Application
Table 91. ChengDu Tecbond PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. ChengDu Tecbond Main Business and Markets Served
Table 93. ChengDu Tecbond Recent Developments/Updates
Table 94. Veterinary PRRS Vaccines Corporation Information
Table 95. Veterinary Specification and Application
Table 96. Veterinary PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Veterinary Main Business and Markets Served
Table 98. Veterinary Recent Developments/Updates
Table 99. Ringpu Biology PRRS Vaccines Corporation Information
Table 100. Ringpu Biology Specification and Application
Table 101. Ringpu Biology PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Ringpu Biology Main Business and Markets Served
Table 103. Ringpu Biology Recent Developments/Updates
Table 104. Qilu Animal PRRS Vaccines Corporation Information
Table 105. Qilu Animal Specification and Application
Table 106. Qilu Animal PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Qilu Animal Main Business and Markets Served
Table 108. Qilu Animal Recent Developments/Updates
Table 109. DHN PRRS Vaccines Corporation Information
Table 110. DHN Specification and Application
Table 111. DHN PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. DHN Main Business and Markets Served
Table 113. DHN Recent Developments/Updates
Table 114. CAVAC PRRS Vaccines Corporation Information
Table 115. CAVAC Specification and Application
Table 116. CAVAC PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. CAVAC Main Business and Markets Served
Table 118. CAVAC Recent Developments/Updates
Table 119. Komipharm PRRS Vaccines Corporation Information
Table 120. Komipharm Specification and Application
Table 121. Komipharm PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Komipharm Main Business and Markets Served
Table 123. Komipharm Recent Developments/Updates
Table 124. Agrovet PRRS Vaccines Corporation Information
Table 125. Agrovet Specification and Application
Table 126. Agrovet PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Agrovet Main Business and Markets Served
Table 128. Agrovet Recent Developments/Updates
Table 129. Bioveta PRRS Vaccines Corporation Information
Table 130. Bioveta Specification and Application
Table 131. Bioveta PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Bioveta Main Business and Markets Served
Table 133. Bioveta Recent Developments/Updates
Table 134. Bioveta PRRS Vaccines Corporation Information
Table 135. Jinyu Bio-Technology Specification and Application
Table 136. Jinyu Bio-Technology PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. Jinyu Bio-Technology Main Business and Markets Served
Table 138. Jinyu Bio-Technology Recent Developments/Updates
Table 139. Institutul Pasteur PRRS Vaccines Corporation Information
Table 140. Institutul Pasteur PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 141. Institutul Pasteur Main Business and Markets Served
Table 142. Institutul Pasteur Recent Developments/Updates
Table 143. MVP PRRS Vaccines Corporation Information
Table 144. MVP Specification and Application
Table 145. MVP PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 146. MVP Main Business and Markets Served
Table 147. MVP Recent Developments/Updates
Table 148. Tecon PRRS Vaccines Corporation Information
Table 149. Tecon Specification and Application
Table 150. Tecon PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 151. Tecon Main Business and Markets Served
Table 152. Tecon Recent Developments/Updates
Table 153. Zoetis PRRS Vaccines Corporation Information
Table 154. Zoetis Specification and Application
Table 155. Zoetis PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 156. Zoetis Main Business and Markets Served
Table 157. Zoetis Recent Developments/Updates
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. PRRS Vaccines Distributors List
Table 161. PRRS Vaccines Customers List
Table 162. PRRS Vaccines Market Trends
Table 163. PRRS Vaccines Market Drivers
Table 164. PRRS Vaccines Market Challenges
Table 165. PRRS Vaccines Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PRRS Vaccines
Figure 2. Global PRRS Vaccines Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global PRRS Vaccines Market Share by Type: 2023 VS 2030
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global PRRS Vaccines Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global PRRS Vaccines Market Share by Application: 2023 VS 2030
Figure 8. Government Tender
Figure 9. Market Sales
Figure 10. Global PRRS Vaccines Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global PRRS Vaccines Production Value (US$ Million) & (2019-2030)
Figure 12. Global PRRS Vaccines Production (K Units) & (2019-2030)
Figure 13. Global PRRS Vaccines Average Price (USD/Unit) & (2019-2030)
Figure 14. PRRS Vaccines Report Years Considered
Figure 15. PRRS Vaccines Production Share by Manufacturers in 2023
Figure 16. PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 17. The Global 5 and 10 Largest Players: Market Share by PRRS Vaccines Revenue in 2023
Figure 18. Global PRRS Vaccines Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 19. Global PRRS Vaccines Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 20. Global PRRS Vaccines Production Comparison by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 21. Global PRRS Vaccines Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 22. North America PRRS Vaccines Production Value (US$ Million) Growth Rate (2019-2030)
Figure 23. Europe PRRS Vaccines Production Value (US$ Million) Growth Rate (2019-2030)
Figure 24. China PRRS Vaccines Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. Japan PRRS Vaccines Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. Global PRRS Vaccines Consumption by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 27. Global PRRS Vaccines Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. North America PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 29. North America PRRS Vaccines Consumption Market Share by Country (2019-2030)
Figure 30. Canada PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 31. U.S. PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 32. Europe PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 33. Europe PRRS Vaccines Consumption Market Share by Country (2019-2030)
Figure 34. Germany PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 35. France PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 36. U.K. PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 37. Italy PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 38. Russia PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 39. Asia Pacific PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 40. Asia Pacific PRRS Vaccines Consumption Market Share by Regions (2019-2030)
Figure 41. China PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 42. Japan PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 43. South Korea PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 44. China Taiwan PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 45. Southeast Asia PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 46. India PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 47. Latin America, Middle East & Africa PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 48. Latin America, Middle East & Africa PRRS Vaccines Consumption Market Share by Country (2019-2030)
Figure 49. Mexico PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 50. Brazil PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 51. Turkey PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 52. GCC Countries PRRS Vaccines Consumption and Growth Rate (2019-2024) & (K Units)
Figure 53. Global Production Market Share of PRRS Vaccines by Type (2019-2030)
Figure 54. Global Production Value Market Share of PRRS Vaccines by Type (2019-2030)
Figure 55. Global PRRS Vaccines Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Production Market Share of PRRS Vaccines by Application (2019-2030)
Figure 57. Global Production Value Market Share of PRRS Vaccines by Application (2019-2030)
Figure 58. Global PRRS Vaccines Price (USD/Unit) by Application (2019-2030)
Figure 59. PRRS Vaccines Value Chain
Figure 60. PRRS Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
